Results 71 to 80 of about 6,998 (166)

Atypical hemolytic-uremic syndrome, manifesting without thrombocytopenia (clinical case)

Известия высших учебных заведений. Поволжский регион: Медицинские науки
Background. Atypical hemolytic uremic syndrome is an ultra-rare (orphan) disease from the group of thrombotic microangiopathies of progressive course, which is caused by uncontrolled activation of the alternative complement pathway of hereditary or ...
A.A. Dyachkova, A.N. Anokhin, M.A. Shlykova, I.S. Kiseleva   +3 more
doaj   +1 more source

An adult case of atypical hemolytic uremic syndrome presented with posterior reversible encephalopathy syndrome: Successful response to late-onset eculizumab treatment

Hematology Reports, 2018
Atypical hemolytic uremic syndrome is a rare and progressive disease caused by uncontrolled alternative complement activation. Dysregulatıon of the complement activation results in thrombotic microangiopathy and multiorgan damage.
Serife Solmaz Medeni, Sinem Namdaroglu, Tugba Cetintepe, Can Ozlu, Funda Tasli, Zehra Hilal Adibelli, Oktay Bilgir, Erhan Tatar   +7 more
doaj   +1 more source

Concurrent Atypical Hemolytic Uremic Syndrome and Autoimmune Hemolytic Anemia: a case report

Caspian Journal of Pediatrics, 2018
Background: Atypical hemolytic uremic syndrome (aHUS) is a life-threatening and scarce disorder characterized by acute renal failure and disease, non-immune microangiopathic hemolytic anemia and thrombocytopenia, leading to end-stage renal failure or ...
Sayed Yousef Mojtahedi, Mohammad Kaji Yazdi   +1 more
doaj  

Reply to Letter: “Limitations of Complement Activity Assays as Biomarkers for Ravulizumab Therapeutic Monitoring” by Saccà and Pelto Regarding “Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab”

Annals of Clinical and Translational Neurology, Volume 13, Issue 6, Page 1303-1304, June 2026.
Lea Gerischer, Jutta Schroeder‐Braunstein, Guido Wabnitz, Andreas Meisel   +3 more
wiley   +1 more source

Eculizumab in Atypical Hemolytic–Uremic Syndrome [PDF]

New England Journal of Medicine, 2013
Christophe M, Legendre, Christoph, Licht, Chantal, Loirat   +2 more
openaire   +7 more sources

Atypical Hemolytic Uremic Syndrome

Advances in Pediatrics, 2014
Kaan GÜLLEROĞLU, Başak GÜLLEROĞLU, Esra BASKIN   +2 more
  +6 more sources

A Case of Severe Pre‐Eclampsia Complicated by HELLP Syndrome and Extensive Hepatic Infarction

Clinical Case Reports
Extensive hepatic infarction is a rare but potentially fatal complication of HELLP syndrome and is often difficult to recognize because of nonspecific clinical manifestations.
Tiange Xia, Fei Gao, Fengming Liang, Yang Shao   +3 more
doaj   +1 more source

Analysis of causes and outcomes of principal secondary thrombotic microangiopathy: a 9-year cohort study from a tertiary pediatric center in China

Research and Practice in Thrombosis and Haemostasis
Background: Few large-scale cohort studies have reviewed consecutive cases of thrombotic microangiopathy (TMA), especially in children. Objectives: The aim of our study was to evaluate causes and outcomes of TMA at a tertiary pediatric center in China ...
Dan Wu, Jie Zheng, Jun Yang, Bin Wang, Guanghua Zhu, Zhi Chen, Qiang Sun, Nan Zhou, Zhenping Chen, Yanhui Luo, Wei Yang, Xiaoyu Tian, Hejia Zhang, Xue Liu, Lei Lei, Na Tian, Kaige Zhang, Li Fang, Lan Mi, Ang Wei, Ying Liang, Maoquan Qin, Xiaorong Liu, Chenguang Jia   +23 more
doaj   +1 more source

Atypical hemolytic uremic syndrome in a child: A rare case report

Clinical Case Reports
Key Clinical Message Atypical hemolytic uremic syndrome, a rare thrombotic microangiopathy, necessitates early diagnosis and comprehensive care due to its potential severity, emphasizing the importance of a multidisciplinary approach to improve outcomes.
Bishal Kunwor, Bishal Sharma, Suchit Thapa Chhetri, Prerana Joshi, Dipendra Pradhan   +4 more
doaj   +1 more source

ATYPICAL HEMOLYTIC UREMIC SYNDROME DIAGNOSIS AND TREATMENT

Hematology, Transfusion and Cell Therapy
Atypical hemolytic uremic syndrome (aHUS), more commonly known as complement-related HUS is a kind of thrombotic microangiopathy (TMA) characterized by inherited pathogenic variants in complement genes or acquired autoantibodies against complement ...
Atakan Turgutkaya
doaj   +1 more source